Mettler-Toledo International, Inc. $MTD Shares Sold by US Bancorp DE

Key Points

• US Bancorp DE has significantly reduced its holdings in Mettler-Toledo International by 44.5% during Q2, now owning 2,234 shares valued at approximately $2.6 million.
• Insiders, including Director Thomas P. Salice, have sold a total of 1,827 shares of the company's stock in the last ninety days, indicating a notable 78.96% decrease in Salice’s position.
• Mettler-Toledo reported earnings of $10.09 per share for the last quarter, beating analysts' expectations, while its stock currently holds a consensus target price of $1,336.50.

US Bancorp DE cut its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 44.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,234 shares of the medical instruments supplier's stock after selling 1,788 shares during the quarter. US Bancorp DE's holdings in Mettler-Toledo International were worth $2,624,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Greenleaf Trust boosted its position in Mettler-Toledo International by 1.2% during the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after acquiring an additional 10 shares during the last quarter. Brooklyn Investment Group boosted its position in Mettler-Toledo International by 12.8% during the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after acquiring an additional 10 shares during the last quarter. Sax Wealth Advisors LLC boosted its position in Mettler-Toledo International by 2.8% during the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier's stock worth $437,000 after acquiring an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after acquiring an additional 11 shares during the last quarter. Finally, Albion Financial Group UT raised its stake in Mettler-Toledo International by 1.5% during the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after purchasing an additional 11 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director directly owned 283 shares of the company's stock, valued at $368,154.70. This represents a 78.96% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the transaction, the chief financial officer owned 5,095 shares of the company's stock, valued at $6,750,875. This trade represents a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 in the last ninety days. Company insiders own 0.77% of the company's stock.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock opened at $1,302.16 on Wednesday. The company's 50 day simple moving average is $1,281.30 and its 200-day simple moving average is $1,191.57. The company has a market capitalization of $26.82 billion, a price-to-earnings ratio of 32.97, a price-to-earnings-growth ratio of 3.86 and a beta of 1.37. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,486.76.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. The business had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business's revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the firm earned $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have commented on MTD. Bank of America lifted their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a research note on Monday, September 22nd. Robert W. Baird lifted their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. Evercore ISI lifted their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 7th. Citigroup lifted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Finally, Barclays lifted their target price on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the stock an "overweight" rating in a research note on Thursday, October 2nd. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Mettler-Toledo International has an average rating of "Hold" and a consensus target price of $1,336.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.